Barrett’s Esophagus Treatment and Management

Explore treatment options for Barrett esophagus. From acid suppression medication to advanced endoscopic ablation, learn how we manage and protect your esophagus.

Treatment and Management

Clinical Management Goals

The primary goal of managing this condition is to prevent the progression to esophageal cancer and to control the underlying acid reflux. Management is divided into two main categories: medical therapy to control acid and endoscopic procedures to remove or treat abnormal tissue. The choice of treatment is heavily dependent on the biopsy results and the presence or grade of dysplasia. At Liv Hospital, we follow a personalized approach, ensuring that each patient receives the right level of intervention for their specific risk profile.

Acid Suppression Therapy

The first line of management for almost everyone with this condition is aggressive acid suppression.

• Proton Pump Inhibitors (PPIs) are the standard choice.
• These medications reduce the amount of acid produced by the stomach.
• They allow the esophageal lining to heal from active inflammation (esophagitis).
• They help prevent further damage to the Barrett tissue.
  

While these medications do not usually make the Barrett tissue disappear, they create a "calmer" environment that reduces the risk of cellular mutations. Consistent use as directed by your clinician is a cornerstone of long term management.

Endoscopic Mucosal Resection (EMR)

If a biopsy shows high grade dysplasia or early stage cancer, a procedure called Endoscopic Mucosal Resection, or EMR, may be performed.

During this procedure, the specialist lifts the abnormal area of the lining by injecting fluid underneath it. Then, a specialized tool is used to "cut" and remove the abnormal patch through the endoscope. The removed tissue is then sent to the lab for a very detailed analysis. EMR is a powerful tool because it can effectively "cure" early stage abnormalities without the need for major surgery.

Radiofrequency Ablation (RFA)

Radiofrequency Ablation, or RFA, is a highly effective treatment for removing Barrett tissue. It involves using heat energy to destroy the abnormal cells.

• A specialized balloon or plate is used to deliver a precise dose of heat.
• Only the very thin, abnormal top layer of the lining is destroyed.
• The healthy tissue underneath is preserved.
• After the procedure, the body heals by growing back a normal, healthy squamous lining.
  

RFA is often performed in several sessions to ensure all the Barrett tissue is eliminated. It is a gold standard for treating dysplasia and significantly reduces the risk of cancer developing.

Cryotherapy Techniques

Cryotherapy is an alternative to heat-based ablation. Instead of heat, it uses extreme cold to destroy the abnormal cells.

• Liquid nitrogen or carbon dioxide is sprayed onto the Barrett tissue through the endoscope.
• The tissue freezes and then thaws, causing the cells to die.
• Like RFA, the goal is for healthy tissue to grow back in its place.
  

Cryotherapy is often used for patients who have irregular or bumpy tissue that is difficult to treat with RFA, or for those who did not respond fully to other ablation methods. It provides another layer of protection in our clinical toolkit.

Surgical Options: Nissen Fundoplication

In some cases, managing the underlying reflux with medication is not enough, or the patient may prefer a more permanent solution. A surgical procedure called Nissen Fundoplication can be performed.

• The surgeon wraps the top part of the stomach around the lower esophagus.
• This reinforces the lower esophageal sphincter.
• It physically prevents acid from refluxing into the esophagus.
  

This surgery is typically done laparoscopically (minimally invasive). While it does not treat the Barrett tissue directly, it provides the most powerful protection against further acid damage.

Management of Low-Grade Dysplasia

When low grade dysplasia is found, the clinical team has two choices: increased surveillance or ablation.

• Surveillance involves an endoscopy every six to twelve months.
• Ablation (RFA) removes the tissue before it can worsen.
  

Recent clinical studies have shown that early ablation for low grade dysplasia can significantly reduce the risk of it turning into high grade dysplasia or cancer. At Liv Hospital, we discuss these options with you, weighing the risks and benefits to decide the best path for your lifestyle and health goals.

Lifestyle Management Strategies

No treatment for this condition is complete without addressing lifestyle habits. Clinicians work with patients to implement changes that reduce reflux naturally.

• Weight loss to reduce abdominal pressure.
• Eating smaller, more frequent meals.
• Avoiding "trigger" foods like chocolate, peppermint, and fatty items.
• Quitting smoking and reducing alcohol intake.
• Not lying down for at least three hours after a meal.
  

These habits support your medical treatments and are essential for the long term health of your esophagus.

Surveillance Schedules and Compliance

For many patients, especially those with no dysplasia, the best "treatment" is a commitment to regular surveillance. A common schedule involves an endoscopy every three to five years. Compliance with this schedule is the most important thing a patient can do. Because cellular changes are microscopic and painless, you cannot rely on how you feel to know if your condition is stable. Regular checkups ensure that if any change occurs, it is caught in the earliest, most treatable stage.

Why Technical Expertise Matters

Procedures like RFA and EMR require a high level of specialized training. The goal is to remove the abnormal tissue without causing scarring or narrowing of the esophagus. At Liv Hospital, our gastroenterologists are experts in advanced interventional endoscopy. We use the most modern equipment to ensure the highest success rates and the fastest recovery times. Choosing a facility with a high volume of these procedures ensures that you are receiving the most refined and safe care available in the global medical market.